Bayesian Capital Management’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,614
Closed -$1.72M 857
2024
Q3
$1.72M Buy
+3,614
New +$1.65M 0.2% 150
2024
Q2
Sell
-6,531
Closed -$3.03M 939
2024
Q1
$3.03M Buy
+6,531
New +$2.83M 0.29% 90
2021
Q4
Sell
-4,591
Closed -$1.35M 459
2021
Q3
$1.35M Sell
4,591
-3,109
-40% -$945K 0.39% 67
2021
Q2
$2.23M Buy
7,700
+5,800
+305% +$1.69M 0.58% 32
2021
Q1
$532K Buy
+1,900
New +$493K 0.12% 217
2020
Q3
Sell
-4,631
Closed -$982K 617
2020
Q2
$982K Sell
4,631
-749
-14% -$145K 0.22% 128
2020
Q1
$931K Sell
5,380
-800
-13% -$158K 0.2% 146
2019
Q4
$1.32M Buy
6,180
+4,080
+194% +$822K 0.23% 131
2019
Q3
$407K Buy
2,100
+1,000
+91% +$194K 0.08% 316
2019
Q2
$221K Buy
+1,100
New +$206K 0.05% 422

Other funds holding LIN

Bayesian Capital Management's LIN Position: Q4 2024 in Review

Bayesian Capital Management sold out of Linde (LIN) in Q4 2024, closing a stake of 3,614 shares — an estimated $1.72M sold.

Bayesian Capital Management first reported a position in LIN in Q2 2019 and held it in 10 quarters. The position peaked at $3.03M in Q1 2024. 2,010 funds tracked by Wall St. Rank hold LIN as of Q4 2024.

  • Bayesian Capital Management reported no remaining Linde position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 3,614 Linde shares in Q4 2024, an estimated $1.72M.
  • Bayesian Capital Management first reported a position in Linde in Q2 2019 and held it in 10 quarters.
  • Bayesian Capital Management's Linde position peaked at $3.03M in Q1 2024.
  • 2,010 funds tracked by Wall St. Rank held Linde as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.